 Advertisement | ||||||||
 | ||||||||
|
||||||||
 |
 |
 |
 |
 |
 |
 |
||
|
From the Kunin-Lunenfeld Applied Research Unit (Rochon, Mashari, Cohen, Misra, Laxer, Streiner, Dergal) and the Rotman Research Institute (Binns), Baycrest Centre for Geriatric Care, Toronto, Ont.; the Departments of Medicine (Rochon), Public Health Sciences (Rochon, Clark) and Psychiatry (Streiner), and the Centre for Research in Women's Health (Clark), University of Toronto, Toronto, Ont.; the Institute for Clinical Evaluative Sciences (Rochon), Toronto, Ont.; and McGill University (Gold), Montreal, Que.
Background: More than two-thirds of the world's population live in low-income countries, where health priorities are different from those of people living in more affluent parts of the world. We evaluated the relation between the global burden of disease and conditions or diseases studied in randomized controlled trials (RCTs) published in general medical journals.
Methods: A MEDLINE search identified 373 RCTs that had been published in 6 international peer-reviewed general medical journals in 1999. Manual review excluded non-RCTs, brief reports and trials in which the unit of randomization was not the patient; 286 RCTs remained eligible for analysis. We identified the RCTs that studied any of the 40 leading causes of the global burden of disease. Five of these conditions were considered unsuitable for study with an RCT design and were excluded from subsequent analysis. To provide a practical perspective, we asked 12 experts working with international health organizations to rate the relevance to global health of the articles that studied any of the top 10 causes of the global burden of disease, as measured by disability-adjusted life years (DALYs) and mortality, using a 5-point Likert scale.
Results: Among the 286 RCTs in our sample, 124 (43.4%) addressed 1 of the 35 leading causes of the global burden of disease. Of these, ischemic heart disease, HIV/AIDS and cerebrovascular disease were the most commonly studied conditions. Ninety articles (31.5%) studied 1 of the top 10 causes of the global burden of disease. The mean rating (and standard deviation) for international health relevance assigned by experts was 2.6 (1.5) out of 5. Only 14 (16%) of the 90 trials received a rating of 4 or greater, indicating high relevance to international health. Almost half of the 40 leading causes of the global burden of disease were not studied by any trial.
Interpretation: Many conditions or diseases common internationally are underrepresented in RCTs published in leading general medical journals. Trials published in these journals that studied one of these high-priority conditions were generally rated as being of little relevance to international health.
Related Article
This article has been cited by other articles:
|
|
 |
|
  P. Sharan, C. Gallo, O. Gureje, E. Lamberte, J. J. Mari, G. Mazzotti, V. Patel, L. Swartz, S. Olifson, I. Levav, et al. Mental health research priorities in low- and middle-income countries of Africa, Asia, Latin America and the Caribbean The British Journal of Psychiatry, October 1, 2009; 195(4): 354 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Beasley, B. Starfield, C. van Weel, W. W. Rosser, and C. L. Haq Global Health and Primary Care Research J Am Board Fam Med, November 1, 2007; 20(6): 518 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Reddy, S. S. Gill, S. R. Kalkar, W. Wu, P. J. Anderson, and P. A. Rochon Oral Drug Therapy for Multiple Neglected Tropical Diseases: A Systematic Review JAMA, October 24, 2007; 298(16): 1911 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Flanagin and M. A. Winker Theme Issue on Poverty and Human Development: Call for Papers on Interventions to Improve Health Among the Poor JAMA, December 27, 2006; 296(24): 2970 - 2971. [Full Text] [PDF]
|
|
|
|
|
|
S. SAXENA, G. PARAJE, P. SHARAN, G. KARAM, and R. SADANA The 10/90 divide in mental health research: trends over a 10-year period The British Journal of Psychiatry, January 1, 2006; 188(1): 81 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marusic, D. Hren, and M. Marusic Peer review of articles on global burden of disease Can. Med. Assoc. J., March 15, 2005; 172(6): 727 - 727. [Full Text] [PDF]
|
|
|
|
|
|
J. Gold and P. A. Rochon Peer review of articles on global burden of disease Can. Med. Assoc. J., March 15, 2005; 172(6): 727 - 728. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Jacques Catering to the customers Can. Med. Assoc. J., November 9, 2004; 171(10): 1150 - 1150. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Rochon, J. Gold, and J. P. Clark Catering to the customers Can. Med. Assoc. J., November 9, 2004; 171(10): 1150 - 1151. [Full Text] [PDF]
|
|
|
|
 |
|
 Minerva BMJ, June 5, 2004; 328(7452): 1386 - 1386. [Full Text] [PDF]
|
|
|
|
|
|
D. Spurgeon Medical journals don't publish trials on major global diseases BMJ, June 5, 2004; 328(7452): 1337. [Full Text]
|
|
|
|
|
|
P. Jha and J. V. Lavery Evidence for global health Can. Med. Assoc. J., May 25, 2004; 170(11): 1687 - 1688. [Full Text]
|
|
Read all eLetters
| HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP | SEARCH |
|
|||||
|
Copyright 1995-2004, Canadian Medical Association. All rights reserved. ISSN 1488-2329
(e) 0820-3946 (p)
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. |
|||||
